全文获取类型
收费全文 | 1206392篇 |
免费 | 87056篇 |
国内免费 | 3023篇 |
专业分类
耳鼻咽喉 | 15683篇 |
儿科学 | 40665篇 |
妇产科学 | 32667篇 |
基础医学 | 175233篇 |
口腔科学 | 32600篇 |
临床医学 | 107609篇 |
内科学 | 240159篇 |
皮肤病学 | 28320篇 |
神经病学 | 97995篇 |
特种医学 | 44782篇 |
外国民族医学 | 387篇 |
外科学 | 176107篇 |
综合类 | 24645篇 |
一般理论 | 448篇 |
预防医学 | 96895篇 |
眼科学 | 26760篇 |
药学 | 86530篇 |
3篇 | |
中国医学 | 2665篇 |
肿瘤学 | 66318篇 |
出版年
2021年 | 10232篇 |
2019年 | 10969篇 |
2018年 | 17374篇 |
2017年 | 12687篇 |
2016年 | 13832篇 |
2015年 | 15622篇 |
2014年 | 19720篇 |
2013年 | 30505篇 |
2012年 | 43771篇 |
2011年 | 45776篇 |
2010年 | 25878篇 |
2009年 | 23061篇 |
2008年 | 41569篇 |
2007年 | 44075篇 |
2006年 | 43513篇 |
2005年 | 42027篇 |
2004年 | 40456篇 |
2003年 | 38391篇 |
2002年 | 36759篇 |
2001年 | 51747篇 |
2000年 | 52975篇 |
1999年 | 44612篇 |
1998年 | 12023篇 |
1997年 | 10780篇 |
1996年 | 10781篇 |
1995年 | 10328篇 |
1994年 | 9595篇 |
1993年 | 8940篇 |
1992年 | 34789篇 |
1991年 | 33736篇 |
1990年 | 33160篇 |
1989年 | 31847篇 |
1988年 | 29090篇 |
1987年 | 29089篇 |
1986年 | 27164篇 |
1985年 | 26149篇 |
1984年 | 19517篇 |
1983年 | 16460篇 |
1982年 | 9844篇 |
1979年 | 17857篇 |
1978年 | 12921篇 |
1977年 | 10967篇 |
1976年 | 10294篇 |
1975年 | 10854篇 |
1974年 | 13160篇 |
1973年 | 12693篇 |
1972年 | 11671篇 |
1971年 | 10892篇 |
1970年 | 10125篇 |
1969年 | 9512篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
95.
96.
IntroductionInterprofessional learning (IPL) is a vital aspect of training in radiation oncology professions, yet is rarely delivered to those professionals who work most closely together in clinical practice. Scenario-based learning using simulation facilities provides a unique opportunity to facilitate this learning and this project aimed to determine the impact and value of this initiative.MethodsSmall groups comprising post-graduate diploma pre-registration therapeutic radiographers, medical physics trainees and radiation oncology registrars were challenged with 4 plausible and challenging radiotherapy scenarios within an academic simulation centre. Pre- and post-event completion of the “Readiness for Interprofessional Learning Scale” measured impact and a Likert-style survey gathered feedback from participants.ResultsThe session increased participants' teamwork and collaboration skills as well as strengthening professional identities. Participants reported high levels of enjoyment related to collaborative working, communication and observing other professionals deploying their technical skills and specialist knowledge.ConclusionAlthough beneficial, simulated scenarios offering equal opportunities for engagement across the professions are challenging to plan and timetabling issues between the 3 groups present significant difficulties. The safe environment and unique opportunity for these groups to learn together was particularly well received and future oncology-specific simulated scenario sessions are planned with larger cohorts.Implications for practiceSimulated scenario training can be used to improve team working across the radiotherapy interprofessional team and may have wider use in other specialist interdisciplinary team development. 相似文献
97.
Naveen B.S. M.T. Mohan J. Tharayil S.T. Joseph 《International journal of oral and maxillofacial surgery》2021,50(8):1003-1008
A local pedicled vascularized bone flap can prevent the morbidity and cost of free bone flap surgery in small segmental bone defects or long cartilaginous defects of the head and neck. Such flaps can also be useful in patients who are high risk for surgery. The periosteal vascularity of the mandible can be used to design islanded facial artery-based bone flaps, which can be utilized to that extent. Two patients with a small segmental mandibulectomy defect and one patient with a long cricotracheal resection defect underwent reconstruction using three different designs of islanded facial artery osteomyomucosal/osseous flap (iFOMM). The patients had a minimum follow-up period of 18 months. All flaps were successful, with satisfactory healing and without any functional deficit or disease at last follow-up. 相似文献
98.
99.
Annals of Nuclear Medicine - Cardiac amyloidosis is a rare disease characterized by amyloid heart deposits and is usually a part of systemic amyloidosis, in relation to systemic light chain (AL)... 相似文献
100.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献